Biogen Pharmachem Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 200854, "name": "Biogen Pharma", "stock_name": "Biogen Pharma", "full_name": "Biogen Pharmachem Industries Ltd", "name_url": "stocks-analysis/biogen-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "0.37", "chg": "0.00", "chgp": "0.00%", "dir": 0, "prev_price": "0.37", "mcapval": "38.96 Cr", "mcap": "Micro Cap", "scripcode": 531752, "symbol": "", "ind_name": "Non Banking Financial Company (NBFC)", "ind_code": 49, "indexname": "India SENSEX", "isin": "INE703D01023", "curr_date": "May 21", "curr_time": "", "bse_nse_vol": "30.61 lacs", "exc_status": "Active", "traded_date": "May 21, 2026", "traded_date_str": "2026 05 21", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4002822", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_mojoScore_4002822.png", "date": "2026-05-21 10:10:22", "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and prospects." }, { "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs036-4002444", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_4002444.png", "date": "2026-05-21 09:40:43", "description": "" }, { "title": "Biogen Pharmachem Industries Ltd: Valuation Shifts Signal Heightened Risk Amidst Weak Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-valuation-shifts-signal-heightened-risk-amidst-weak-returns-3995843", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_valuationdot_3995843.png", "date": "2026-05-18 08:00:20", "description": "Biogen Pharmachem Industries Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen a marked deterioration in its valuation metrics, prompting a downgrade to a Strong Sell rating. With its price-to-earnings (P/E) ratio soaring to 45.45 and price-to-book value (P/BV) plummeting to 0.44, the stock’s price attractiveness has shifted from very expensive to risky, raising concerns among investors amid weak returns and poor profitability indicators." }, { "title": "Biogen Pharmachem Industries Ltd Falls 8.89% Amidst Deepening Operational Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-889-amidst-deepening-operational-challenges-3995575", "imagepath": "", "date": "2026-05-17 14:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock hits 52-week low of Rs.0.43 amid broad market weakness</p>\n <p><strong>13 May:</strong> New 52-week low of Rs.0.42 recorded despite Sensex recovery</p>\n <p><strong>14 May:</strong> Further decline to Rs.0.41, continuing bearish momentum</p>\n <p><strong>15 May:</strong> Stock falls to Rs.0.38, marking a three-day losing streak</p>\n <p><strong>15 May:</strong> Q4 FY26 results reveal mounting losses, signalling operational challenges</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div ..." }, { "title": "Are Biogen Pharmachem Industries Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-biogen-pharmachem-industries-ltd-latest-results-good-or-bad-3993308", "imagepath": "", "date": "2026-05-15 19:22:03", "description": "Biogen Pharmachem Industries Ltd's latest financial results reveal significant operational challenges and persistent losses. The company reported a net profit of -₹0.36 crores for the quarter ended March 2026, marking a year-on-year decline of 130.51% compared to a profit of ₹1.18 crores in the same quarter the previous year. This deterioration is compounded by the fact that the company has reported zero net sales for seven consecutive quarters, indicating a critical operational failure or a potential business shutdown.\n\nThe operating profit for the latest quarter also reflected a loss of ₹0.36 crores, a stark contrast to the operating profit of ₹0.46 crores reported in the previous quarter. This represents a dramatic swing in financial performance, highlighting the company's inability to generate sustainable revenue. The return on equity (ROE) stands at a low 2.51%, suggesting weak capital efficiency and i..." }, { "title": "Biogen Pharmachem Industries Q4 FY26: Mounting Losses Signal Deepening Operational Crisis", "link": "https://www.marketsmojo.com/news/result-analysis/biogen-pharmachem-industries-q4-fy26-mounting-losses-signal-deepening-operational-crisis-3992715", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_quaterlyResult_3992715.png", "date": "2026-05-15 09:46:40", "description": "Biogen Pharmachem Industries Ltd., a micro-cap non-banking financial company, reported a net loss of ₹0.36 crores in Q4 FY26, marking a sharp reversal from the ₹0.46 crores profit recorded in the previous quarter. The loss represents a deterioration of 178.26% on a quarter-on-quarter basis and a 130.51% decline year-on-year compared to the ₹1.18 crores profit in Q4 FY25. With a market capitalisation of just ₹42.00 crores and the stock trading at ₹0.39, the company faces mounting operational challenges that have eroded investor confidence." }, { "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.38 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-stock-falls-to-52-week-low-of-rs038-3992259", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3992259.png", "date": "2026-05-15 09:35:08", "description": "A sharp decline over the past three sessions has dragged Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.38 on 15 May 2026, marking a 56.04% drop over the last year and signalling sustained pressure on this micro-cap NBFC stock despite broader market gains." }, { "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs041-3991185", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3991185.png", "date": "2026-05-14 10:35:04", "description": "Despite a broadly positive market mood with the Sensex gaining 0.27% today, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs 0.41, extending its recent downward trajectory amid persistent selling pressure." }, { "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.42 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs042-3989693", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_3989693.png", "date": "2026-05-13 15:35:07", "description": "A sharp decline has pushed Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.42 on 13 May 2026, marking a significant 61% drop from its peak of Rs 1.08 within the last year. This downturn comes despite some improvement in profitability, highlighting a complex interplay of valuation and market sentiment pressures." } ], "total": 98, "sid": "200854", "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854" }, "announcements": [ { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "19-May-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Interface Financial Services Ltd", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Allotment", "datetime": "18-May-2026", "details": "PFA", "source": "BSE" }, { "caption": "Board Meeting Outcome for Audited Financial Results Of The Company For The Quarter And Year Ended On 31St March 2026 And Outcome Of The Board Meeting Held On Thursday 14Th May 2026.", "datetime": "14-May-2026", "details": "This is to inform you that Outcome of the Board Meeting of the Company held on today i.e. Thursday 14th May 2026 in accordance with SEBl (Listing Obligations and Disclosures Requirements) Regulations 2015 has been approved by the Board of Directors of the Company and taken on record inter-alia the following items; 1.) Consideration and Approval of Audited Financial Result for the Year ended 31st March 2026. 2.) Independent Auditors Report in pursuance with Regulation 33 of SEBI (LODR) Regulations 2015 for the F.Y. 31st March 2026. Further we hereby declare that the Auditor of the Company has issued the Audit report under the Companies Act 2013 and financial results as prepared under SEBI (Listing obligations and Disclosure Requirements) Regulations 2015 for the financial year ended on March 31 2026 with Unmodified Opinion. The board meeting commenced at 04.00 PM and concluded at 04:30 PM. We request you to kindly take on record the same. Thanking You.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Biogen Pharmachem Industries Ltd has announced <strong>1:6</strong> bonus issue, ex-date: 15 May 26", "dt": "2026-05-15", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

11 May: Stock hits 52-week low of Rs.0.43 amid broad market weakness

13 May: New 52-week low of Rs.0.42 recorded despite Sensex recovery

14 May: Further decline to Rs.0.41, continuing bearish momentum

15 May: Stock falls to Rs.0.38, marking a three-day losing streak

15 May: Q4 FY26 results reveal mounting losses, signalling operational challenges

Week Open

Read full news article

Are Biogen Pharmachem Industries Ltd latest results good or bad?

2026-05-15 19:22:03

Biogen Pharmachem Industries Ltd's latest financial results reveal significant operational challenges and persistent losses. The company reported a net profit of -₹0.36 crores for the quarter ended March 2026, marking a year-on-year decline of 130.51% compared to a profit of ₹1.18 crores in the same quarter the previous year. This deterioration is compounded by the fact that the company has reported zero net sales for seven consecutive quarters, indicating a critical operational failure or a potential business shutdown. The operating profit for the latest quarter also reflected a loss of ₹0.36 crores, a stark contrast to the operating profit of ₹0.46 crores reported in the previous quarter. This represents a dramatic swing in financial performance, highlighting the company's inability to generate sustainable revenue. The return on equity (ROE) stands at a low 2.51%, suggesting weak capital efficiency and i...

Read full news article

Biogen Pharmachem Industries Q4 FY26: Mounting Losses Signal Deepening Operational Crisis

2026-05-15 09:46:40

Biogen Pharmachem Industries Ltd., a micro-cap non-banking financial company, reported a net loss of ₹0.36 crores in Q4 FY26, marking a sharp reversal from the ₹0.46 crores profit recorded in the previous quarter. The loss represents a deterioration of 178.26% on a quarter-on-quarter basis and a 130.51% decline year-on-year compared to the ₹1.18 crores profit in Q4 FY25. With a market capitalisation of just ₹42.00 crores and the stock trading at ₹0.39, the company faces mounting operational challenges that have eroded investor confidence.

Read full news article

Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.38 as Sell-Off Deepens

2026-05-15 09:35:08

A sharp decline over the past three sessions has dragged Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.38 on 15 May 2026, marking a 56.04% drop over the last year and signalling sustained pressure on this micro-cap NBFC stock despite broader market gains.

Read full news article

Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-05-14 10:35:04

Despite a broadly positive market mood with the Sensex gaining 0.27% today, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs 0.41, extending its recent downward trajectory amid persistent selling pressure.

Read full news article

Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.42 as Sell-Off Deepens

2026-05-13 15:35:07

A sharp decline has pushed Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.42 on 13 May 2026, marking a significant 61% drop from its peak of Rs 1.08 within the last year. This downturn comes despite some improvement in profitability, highlighting a complex interplay of valuation and market sentiment pressures.

Read full news article